Financials data is unavailable for this security.
View more
Year on year Susmed Inc 's revenues fell -35.44% from 530.65m to 342.58m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 50.75m to a larger loss of 357.42m.
Gross margin | 96.58% |
---|---|
Net profit margin | -104.33% |
Operating margin | -106.36% |
Return on assets | -7.12% |
---|---|
Return on equity | -7.54% |
Return on investment | -7.53% |
More ▼
Cash flow in JPYView more
In 2024, Susmed Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 37.37m or 10.91% of revenues. In addition the company used 230.76m for operations while cash used for investing totalled 8.53m.
Cash flow per share | -12.79 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 274.73 |
---|---|
Tangible book value per share | 274.22 |
More ▼
Balance sheet in JPYView more
Current ratio | 15.24 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼